Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$13.27 - $18.48 $23,249 - $32,376
-1,752 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$14.49 - $20.72 $189,080 - $270,375
-13,049 Reduced 88.16%
1,752 $28 Million
Q4 2020

Feb 12, 2021

BUY
$14.61 - $22.14 $216,242 - $327,694
14,801 New
14,801 $313,000
Q1 2020

May 15, 2020

SELL
$10.23 - $24.56 $179,659 - $431,322
-17,562 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.42 - $26.61 $305,930 - $467,324
17,562 New
17,562 $412,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $186M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.